Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Sevara Khudayarova

Работ: 9

Tashkent Medical Academy, Neurology, Tashkent, Uzbekistan

  1. Clinical and neurological features of the course of parkinsonism in the presence of chronic renal disease

    Sevara Khudayarova, G. Rakhmatullaeva, K. Khalimova

    СтатьяNeurological Disorders and TreatmentsParkinsonism & Related Disorders2020Цитирований: 0
    ABI

  2. Sleep disorders in patients with chronic kidney disease

    Sevara Khudayarova, Gulnara Rakhatullaeva

    СтатьяHealth and Lifestyle StudiesJournal of the Neurological Sciences2021Цитирований: 0
    ABI

  3. FEATURES OF COGNITIVE DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND THE EFFECT OF CYSTATIN C ON IT DEPENDING ON THE STAGE OF THE DISEASE

    Sevara Khudayarova

    СтатьяNeurological Disorders and TreatmentsFrontline Medical Sciences and Pharmaceutical Journal2022Цитирований: 0
    ABI

  4. Cognitive disorders in patients with chronic kidney disease(CKD) and its relationship with the concentration in the blood of the biomarker of kidney damage cystatin C

    Sevara Khudayarova, Gulnara Rakhmatullaevna

    СтатьяNeurological Disorders and TreatmentsJournal of the Neurological Sciences2023Цитирований: 0
    ABI

  5. The role of brain-derived neurotrophic factor during Parkinson's disease

    Bahtigul Holmuratova, Nilufar Rashidova, K. Khalimova +1

    СтатьяAutism Spectrum Disorder ResearchParkinsonism & Related Disorders2024Цитирований: 0
    ABI

  6. Examination of cognitive function in Parkinson's disease patients with chronic kidney disease

    Sevara Khudayarova, G.K. Rakhmatullayeva, Bahtigul Holmuratova

    СтатьяDementia and Cognitive Impairment ResearchParkinsonism & Related Disorders2024Цитирований: 0
    ABI

  7. Vascular remodeling in patients with CKD as a risk factor for the development of vascular Parkinsonism

    Sevara Khudayarova, G. Rakhmatullayeva, Bahtigul Holmuratova

    СтатьяNeurological Disorders and TreatmentsParkinsonism & Related Disorders2024Цитирований: 0
    ABI

  8. Cystatin C as a Biomarker for the Development of Parkinson disease in Patients with Chronic Kidney Disease

    Sevara Khudayarova, G.K. Rakhmatullayeva

    СтатьяDialysis and Renal Disease ManagementParkinsonism & Related Disorders2025Цитирований: 0
    ABI

  9. Efficacy of ocrelizumab in primary progressive multiple sclerosis

    Sevara Khudayarova, Gulnara Rakhmatullayeva

    СтатьяMultiple Sclerosis Research StudiesJournal of the Neurological Sciences2025Цитирований: 0
    ABI